Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-09

Clinical Trial Update: Pro-active Fecal Calprotectin Monitoring PROMOTE-UC

View source ↗

Summary

The PROMOTE-UC clinical trial evaluating proactive fecal calprotectin monitoring for ulcerative colitis is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of British Columbia | Conditions: Ulcerative Colitis | Status: ACTIVE_NOT_RECRUITING